Press Release-Biomedical Pharma and Marchetti Tech sign an agreement for the next 5 years

The two companies joined to develop paints that can guarantee sanitary safety on surfaces

Marchetti Tech Srl, leading company in the production of high-tech paints, manufacturer of Graphene-based paints (GRAFY-TECH™ and GRAFY-COATING™), has signed a 5 years agreement with Biomedical Pharma of Prato, company specialized in health safety and owner of important patents.

"This contract is signed by two companies linked by the same spirit, the sense of protection for people, for the planet and the passion that moves our laboratories", so begins the CEO of Marchetti Tech Joseph Anthony Miceli. "In Biomedical Pharma we have found an ally to carry out our projects on the circular economy to make possible ideas that until yesterday were only dreams. Omar Alessandrini, CEO of Biomedical Pharma declares: "we are happy to work with Marchetti Tech and today we put our know-how in the hands of a high-profile company. We are happy to see our investments transformed into applications that can make the sanitization effective and permanebt for the general public." He adds: "Biomedical Pharma feels all the responsibility to promote the PhotoActive product to the general public andwe can do this through leading companies in various sectors".

Eng. Tiziano Boccomino, CTO of Marchetti Tech, congratulates Biomedical Pharma for the results achieved so far and to receive the tests from the various laboratories that, in the United States, Germany, Italy, China, are working tirelessly to confirm the work of the last two years. He adds: “this type of nanotechnology allows us to obtain sanitized surfaces for a duration of at least 12 months”.

No information was given on the financial value of the agreement, even though it was valued at several million euros.